Revelstoke Capital Partners has announced it has exited its investment in Carrus.

Carrus, based in Lehi, Utah, provides healthcare learning content, continuing education and certification management. Founded in 1992, the company states it has provided education to more than 100,000 healthcare professionals.

Revelstoke Capital Partners, based in Denver, focuses on investing in the healthcare and related business services sectors. Founded in 2013, the firm typically invests between $10 million and $250 million.

Carrus is combining with Penn Foster.

Terms of the sale were not disclosed.

Wellspring Capital Management has acquired Pentec Health, according to a news release.

Pentec Health, based in Glen Mills, Pa., is a provider of compounded sterile medications. The company’s formulations are used for administration in dialysis centers as well as providing in-home targeted drug delivery through nursing services and complex pharmaceutical products to patients who require access outside of a hospital setting.

Wellspring, based in New York, is a middle market private equity firm with approximately $2 billion of private equity capital under management. Founded in 1995, the firm pursues controlling investments in companies with $100 million to $1 billion in enterprise value and $20 million to $100 million in EBITDA in healthcare services and several other sectors.

Terms of the acquisition were not disclosed.

The Wall Street Journal is reporting that NovaQuest Capital Management has spun off its private equity unit into a new entity.

The entity, QHP Capital, is now pitching its second fund and targeting $425 million, according to the Wall Street Journal’s report that’s based on regulatory filings and discussions with people familiar with the fundraising. QHP is expected to continue operating as a healthcare investor in lower midmarket tech-enabled pharmaceutical services companies.

Based in Raleigh, N.C., and formed in 2000, NovaQuest Capital Management provides strategic capital to life science and healthcare companies.

WindRose Health Investors has announced it has completed the sale of Vital Decisions to Evolent Health.

Vital Decisions, based in Edison, N.J., is a provider of technology-enabled advance care-planning services. Founded in 2006, the company provides collaborative decision making and advance care-planning support for members of a health plan’s population through a suite of telehealth and digital solutions.

WindRose, based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.

Evolent Health (NYSE: EVH), based in Arlington, Va., is a developer of software to help providers manage value-based care programs.

Terms of the transaction were not disclosed.

WindRose completed its majority investment in Vital Decisions in December 2012

Pharos Capital Group has announced it has acquired THEMA Health Services.

THEMA, based in Prescott, Ariz., is a provider of hospice, skilled home health and palliative care services throughout Arizona. Founded in 1996, the company provides hospice care, including routine medical care, pain and symptom management, and emotional and spiritual support for terminally ill patients.

Pharos Capital Group, with offices in Dallas and Nashville, pursues control equity and mezzanine investments in lower and middle market companies primarily in healthcare and business services. Founded in 1998, the firm targets the provider services and non-reimbursement industries within healthcare.

Terms of the acquisition were not disclosed.

1315 Capital has announced it has acquired Homestead Smart Health Plans.

Homestead Smart Health Plans, based in Philadelphia, operates in the reference-based pricing solutions market. It serves employers with a technology platform and service offerings, including third-party administration, reference-based pricing and stop-loss insurance.

1315 Capital, based in Philadelphia, is a healthcare-focused growth equity firm that invests in commercial stage companies across healthcare services, medical devices and therapeutics/pharmaceutical services. Founded in 2014, the seeks to invest between $10 million and $30 million in commercial healthcare businesses that have the potential to scale to $50 million to $150 million of revenue.

MoonSail Capital joined 1315 Capital in the investment. With offices San Juan, Puerto Rico, MoonSail is a private equity firm with a special focus in healthcare services acquisition platforms where it seeks to partner with investor groups in control buyouts.

Terms of the acquisition were not disclosed.

Atlantic Street Capital has announced it has acquired Prestige Medical Imaging (PMI).

PMI, based in Newburgh, N.J., is a medical imaging solutions company providing equipment service, maintenance and support to hospitals, physician practices, ambulatory surgery centers and sports teams across the United States. Founded in 2003, the company describes itself as the “largest independent radiology service and solutions provider in the Eastern United States.”

Atlantic Street, based in Stamford, Conn., seeks control equity investments in lower middle market businesses. Founded in 2006, the firm has wide flexibility on investment size in healthcare and other industries. Within healthcare, Atlantic Street targets companies in the provider services, life sciences/pharmaceutical and non-reimbursement industries.

Terms of the acquisition were not disclosed.

Amulet Capital Partners has announced it has acquired Remedy Health Media.

Remedy, with offices in New York and Arlington, Va., is a digital health platform that serves patients, caregivers and healthcare providers. Its health information websites include healthcentral.com, thebody.com and patientpower.info.

Amulet, based in Greenwich, Conn., is a middle market private equity investment firm focused exclusively on the healthcare sector. Founded in 2012, the firm typically invests between $25 million and $150 million in healthcare companies within segments that include life sciences outsourcing, payors and payor services, and providers and outsourced services.

Amulet acquired Remedy from Topspin Consumer Partners, a private equity firm focused on the consumer sector.

Terms of the acquisition were not disclosed.

Altaris Capital Partners has announced it has agreed to sell BK Medical to General Electric (NYSE:GE) for a cash purchase price of $1.45 billion.

BK Medical, with its U.S. headquarters in Boston, is a developer of intraoperative imaging and surgical navigation. Founded in 1992, the company’s solutions are used to guide clinicians during minimally invasive and robotic surgeries and to visualize deep tissue during procedures in neuro and abdominal surgery, and in ultrasound urology.

GE indicated that the acquisition would help its GE Healthcare division further expand beyond diagnostics into surgical and therapeutic interventions.

Altaris, based in New York, seeks control and minority equity investments exclusively in healthcare. Founded in 2002, the firm targets companies within the life sciences/pharmaceutical, provider services and non-reimbursement healthcare industries. Altaris is flexible in its investment sizes.

The transaction is expected to close in 2022.

Audax Private Equity has announced it has acquired GCX Mounting Solutions.

GCX, with its North American operations based out of Petaluma, Cali., is a global designer and manufacturer of healthcare-focused mounting and mobility solutions. Founded in 1971, the company’s products include wall mounts, roll stands, carts and a variety of mounting accessories.

Audax, with private equity offices in Boston, New York and San Francisco, focuses on investments in middle market companies and has a wide flexibility on investment size. Founded in 1999, the firm targets companies within healthcare and several other industries, specifically those generating between $10 million and $50 million in annual EBITDA.

Terms of the acquisition were not disclosed.